, /PRNewswire/ -- (: IPHS) ('' or the 'Company') and (''), a shareholder of , with ownership of 1.07% of the Company's outstanding shares, today announced that the Company has appointed , Chairman, President and Chief Executive Officer of Ferro Corporation, and , Former Acting Chief Executive Officer and long-time Chief Financial Officer of , to the Company's Board of Directors, effective immediately. and will be included in the Company's slate of director nominees for election at the Company's 2016 Annual Meeting. With these changes, the Innophos Board has been expanded to nine directors, eight of whom are independent.

'The Innophos Board of Directors regularly reviews its composition to ensure that the Company directors have the appropriate mix of skills and experience necessary to support the Company and its shareholders,' said , Lead Independent Director of the Innophos Board. 'To that end, we are pleased to welcome Peter and Robert to the Board, and believe that their insights and expertise in the specialty chemical sector will add valuable perspective. The Board and management team are committed to creating value, and we will continue to take decisive actions to capture opportunities to drive growth, generate strong cash flow and improve the overall operating efficiency of our Company, as we continue to manage through the challenging market environment. We look forward to working with Peter and Robert as we strengthen the Company's position as a leading producer of specialty ingredients to create enhanced value for shareholders.'

In connection with today's announcement, and have entered into an agreement pursuant to which FrontFour will support the Innophos Board of Director's slate of nominees at the 2016 Annual Meeting and abide by customary standstill provisions until the date that is thirty (30) days prior to the deadline for submission of shareholder nominations of director candidates for election at the Company's 2017 Annual Meeting. The complete agreement will be included as an exhibit to a Current Report on Form 8-K, which will be filed by with the ('').

'We have had productive dialogue with over the past several months and are pleased with the agreement we entered into with the Company, which we believe benefits all shareholders,' said , Managing Member of . 'Peter and Robert bring a wealth of experience and knowledge that complements the current Directors and we believe they will be strong additions to the Board. We have been encouraged by the recent leadership transition and operational initiatives to improve the Company's performance. We look forward to continuing to work collaboratively with the Board to continue to enhance shareholder value.'

The Innophos Board will present its recommended slate of director nominees in the Company's definitive proxy statement and other materials, to be filed with the and mailed to all shareholders eligible to vote at the 2016 Annual Meeting, which has yet to be scheduled. Under the terms of the agreement with , one existing member of the Board who is yet to be determined will not stand for re-election at the 2016 Annual Meeting.

is serving as legal advisor to and is serving as financial advisor. is serving as legal advisor to .

About

has served as the President and Chief Executive Officer and a director of Ferro Corporation ('Ferro'), a publicly-traded producer of specialty materials, since . Previously, he served as interim President and Chief Executive Officer of Ferro beginning in . was elected Chairman of the Board of Directors of Ferro in . Prior to his appointment as interim President and Chief Executive Officer of Ferro, served as the Operating Vice President of Ferro's , which included its Polymer Additives, Specialty Plastics, Tile Coatings, Porcelain Enamel, and Pharmaceuticals businesses. joined Ferro in 1999 as Director of Sales for Polymer Additives. Prior to joining Ferro, from 1991 to 1999, held various positions at , a specialty chemical company, including Vice President of the Oleochemical-Derivatives business unit, Vice President of Sales and Global Market Director. earned his BS in Chemistry from and his MBA from .

About

Mr. was the Acting Chief Executive Officer and Chief Financial Officer of ('Rockwood'), a leading global developer, manufacturer and marketer of specialty chemicals, from and , respectively, until . Mr. Zatta was instrumental in leading the transformation of Rockwood, which resulted in Rockwood's acquisition by Albermarle Corporation on . Prior to joining Rockwood, Mr. Zatta spent twelve years with the Campbell Soup Company, where he held several significant financial management positions, including his final position as Vice President responsible for Corporate Development and Strategic Planning. Prior to joining Campbell Soup Company in 1990, he worked for and , Inc. is also a member of the of .

About

is a leading international producer of performance-critical and nutritional specialty ingredients, with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. combines more than a century of experience in specialty phosphate manufacturing with a growing capability in a broad range of other specialty ingredients to supply a product range produced to stringent regulatory manufacturing standards and the quality demanded by customers worldwide. is continually developing new and innovative specialty ingredients addressing specific customer applications and supports these high-value products with industry-leading technical service. Headquartered in , has manufacturing operations in ; ; (Waterway), IL; ; ; ; ; ; , ON (); Taicang (); and de (), ). For more information please visit www.innophos.com. 'IPHS-G'

About

is an investment adviser with offices in and . focuses on value-oriented investments in North American companies.

Safe Harbor for Forward-Looking and Cautionary Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. As such, final results could differ from estimates or expectations due to risks and uncertainties, including but not limited to: incomplete or preliminary information; changes in government regulations and policies; continued acceptance of Innophos' products and services in the marketplace; competitive factors; technological changes; Innophos' dependence upon suppliers; and other risks. For any of these factors, Innophos claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, as amended.

Contact Information for , Inc.
Mark Feuerbach
(609) 366-1299
investor.relations@innophos.com

, Wilkinson Brimmer Katcher
/ / Adam Pollack
(212) 355-4449

Contact Information for FrontFour Capital Group LLC
Stephen E. Loukas
(203) 274-9050

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/innophos-to-appoint-peter-t-thomas-and-robert-j-zatta-to-board-of-directors-300202453.html

SOURCE

Innophos Holdings Inc. issued this content on 2016-01-11 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 2016-01-11 21:13:14 UTC

Original Document: http://ir.innophos.com/releasedetail.cfm?ReleaseID=949826